Candida glabrata infection of a pancreatic pseudocyst in a COVID-19 patient: A case report and review of the literature

• Main Authors: Khan, Mohammad Aasim, Almas, Talal, Ullah, Muneeb, Alkhattab, Maha, Shaikh, Fathema, Shaikh, Sufyan, Bagwe, Isha, Antony, Meetty, Khedro, Tarek, Nagarajan, Vikneswaran Raj, Ramjohn, Joshua, Alsufyani, Reema, Almubarak, Dana, Al-Awaid,, Abdulla Hussain, Alsufyani, Majid, Khan, Muhammad Omer, Huang, Helen, Oruk, Mert, Samy, Arjun, Alqallaf, Nagi, Shafi, Adil, Adeel, Aqsa, Khan, Muhammad Kashif, Nagarajan, Dhineswaran Raj *
• Format: Article
• Published: Lippincott Williams & Wilkins 2022
• Subjects: QP Physiology; RC Internal medicine
• Online Access: http://eprints.sunway.edu.my/3137/; https://journals.lww.com/annals-of-medicine-and-surgery/fulltext/2022/05000/candida_glabrata_infection_of_a_pancreatic.95.aspx

Introduction Pancreatic pseudocysts remain a feared complication of acute or chronic pancreatitis and are often characterized by collections of fluids due to underlying damage to the pancreatic ducts, culminating in a walled-off region bereft of an epithelial layer but surrounded by granulation tissue. While fungal infections of pancreatic pseudocysts are rarely encountered, candida albicans remains the most frequently implicated organism. Case presentation A 55-year-old male presented with pain in the left-hypochondriac region, accompanied by non-bilious emesis and nausea. Interestingly, the patient also tested positive for a COVID-19 infection. Investigative workup divulged enhancing pancreatic walls with a radiologic impression consistent with a pancreatic pseudocyst. An ultrasound-guided external drainage was performed; the drainage was conducted unremarkably, with the resultant fluid collection revealing the presence of Candida Glabrata. The patient was commenced on antifungal therapy and continues to do well to date. Discussion Infectious ailments of pancreatic pseudocysts remain a widely known complication of acute pancreatitis. While it is rare, fungal infection is a crucial consideration for patients with pancreatic pseudocysts, especially in the context of a lack of an adequate response to antibiotics, deterioration, comorbidities, and immunocompromised states. Conclusion Rapid identification of the microbe responsible for pancreatic pseudocyst infection is vital for time-sensitive treatment and a more rapid recovery, curbing associated morbidity and mortality.